Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07454148

CART-BP Prospective Study for Hypertension Control

Efficacy and Safety of Cuffless Ambulatory Blood Pressure Monitoring Device-Guided Blood Pressure Management in Korean Patients With Uncontrolled Hypertension: A Prospective Non-Randomized Study

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
288 (actual)
Sponsor
Korea University Anam Hospital · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

This prospective, open-label, non-randomized study evaluates the effectiveness and safety of a CART BP pro(a brand name of cuffless ambulatory blood pressure monitoring device)-guided blood pressure management strategy in Korean patients with uncontrolled hypertension. Participants are allocated to either a CART BP pro-guided management group or a usual care group based on clinical decision and participant preference. The primary efficacy endpoint is 24-hour mean ambulatory systolic blood pressure at 24 weeks; safety outcomes including treatment-emergent adverse events (TEAEs) are also assessed.

Detailed description

Hypertension remains suboptimally controlled despite combination pharmacotherapy, and office blood pressure measurements may not adequately reflect true ambulatory blood pressure burden and nocturnal patterns. CART BP pro is a wearable, cuffless photoplethysmography-based continuous blood pressure monitoring device. This study investigates whether a CART BP pro-guided antihypertensive titration strategy improves 24-hour ambulatory blood pressure control compared with usual care in real-world outpatient settings. Participants receive standard antihypertensive medications (e.g., angiotensin receptor blocker \[ARB\], calcium channel blocker \[CCB\], thiazide diuretic) per guideline-based care. In the CART BP pro-guided group, medication adjustments are informed by CART BP pro-derived 24-hour blood pressure data. Follow-up is 24 weeks with optional extended follow-up to 48 weeks.

Conditions

Interventions

TypeNameDescription
DEVICECART BP proWearable cuffless continuous blood pressure monitoring device.
OTHERUsual care (office BP-based management)Standard hypertension management based on office blood pressure.

Timeline

Start date
2025-03-25
Primary completion
2026-05-04
Completion
2026-05-04
First posted
2026-03-06
Last updated
2026-03-10

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT07454148. Inclusion in this directory is not an endorsement.